iShares iBonds Dec 2045 Term Treasury ETF (NASDAQ:IBGB – Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 3,107 shares, a decrease of 40.0% from the September 30th total of 5,177 shares. Currently, 0.6% of the shares of the stock are short sold. Based on an average daily trading volume, of 2,597 shares, the short-interest ratio is currently 1.2 days.
iShares iBonds Dec 2045 Term Treasury ETF Price Performance
Shares of NASDAQ:IBGB traded up $0.05 during midday trading on Monday, hitting $23.29. The stock had a trading volume of 71,378 shares, compared to its average volume of 3,559. The company’s 50-day moving average price is $22.92 and its 200-day moving average price is $23.98. iShares iBonds Dec 2045 Term Treasury ETF has a fifty-two week low of $22.08 and a fifty-two week high of $25.55.
iShares iBonds Dec 2045 Term Treasury ETF Cuts Dividend
The company also recently declared a monthly dividend, which will be paid on Thursday, November 5th. Investors of record on Monday, November 2nd will be given a dividend of $0.0814 per share. The ex-dividend date is Monday, November 2nd. This represents a $0.98 annualized dividend and a dividend yield of 4.2%. This is a negative change from iShares iBonds Dec 2045 Term Treasury ETF’s previous monthly dividend of $0.0943.
iShares iBonds Dec 2045 Term Treasury ETF Company Profile
iShares Trust – iShares iBonds Dec 2025 Term Treasury ETF is an exchange traded fund launched by BlackRock, Inc The fund is managed by BlackRock Fund Advisors. It invests in the fixed income markets of the United States. The fund uses derivatives such as futures, options and swaps to create its portfolio. The fund primarily invests in publicly-issued U.S. Treasury securities with a fixed coupon schedule and be denominated in U.S. dollars. It invests in securities that will mature between January 1, 2045 and December 15, 2045.
See Also
- Five stocks we like better than iShares iBonds Dec 2045 Term Treasury ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for iShares iBonds Dec 2045 Term Treasury ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2045 Term Treasury ETF and related companies with MarketBeat.com's FREE daily email newsletter.
